Literature DB >> 11291109

Negative interference of bilirubin and hemoglobin in the MEIA troponin I assay but not in the MEIA CK-MB assay.

A Dasgupta1, A Wells, D A Biddle.   

Abstract

Troponin I is a sensitive and specific marker for the diagnosis of myocardial infarction. Several commercially available immunoassays measure the concentration of troponin I in serum. The microparticle enzyme immunoassay (MEIA) for troponin I (Abbott Laboratories, Abbott Park, IL) is widely used in clinical laboratories, including our hospital laboratory. We studied the effect of bilirubin and hemolysis on the MEIA for troponin I and compared our assay with a newly available chemiluminescent assay (CLIA) for troponin I (Bayer Diagnostics, Tarrytown, NY). We also measured CK-MB concentration using the MEIA CK-MB assay. One serum pool was prepared by combining several specimens of one patient with elevated troponin I and with a diagnosis of myocardial infarction. Other serum pools were prepared by combining sera with similar troponin I values. All serum pools showed normal bilirubin concentrations and had no hemolysis. Then we supplemented aliquots of serum pools with various concentrations of bilirubin (5.0, 10.0, 15.0, and 20.0 mg/dL). After supplementation, troponin I concentrations were measured again using the MEIA and CLIA. We observed a statistically significant decrease in troponin I concentration in the presence of bilirubin with the MEIA. For example, in serum pool 1, the troponin I concentration was 16.3 (bilirubin: 0.8 mg/dL). In the presence of 5.0, 10.0, 15.0 and 20.0 mg/dL of added bilirubin, the cardiac troponin I concentrations were 13.9, 13.4, 13.3 and 13.0 ng/ml respectively. We observed similar negative interference of bilirubin in troponin I measurement by the MEIA in other pools. The troponin I value decreased slightly (not statistically significant) in one pool and did not change in two other pools in the presence of bilirubin when we measured troponin I concentration using the CLIA. Interestingly, bilirubin did not interfere with the MEIA CK-MB assay. Moderate hemolysis did not have any effect on the troponin I assay using either the MEIA or CLIA. However, gross hemolysis (hemoglobin > 40 mg/dL) interfered with both assays for troponin I.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11291109      PMCID: PMC6807833          DOI: 10.1002/jcla.5

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  16 in total

Review 1.  Cardiac troponin. How specific is specific?

Authors:  J L Bock
Journal:  Am J Clin Pathol       Date:  1999-12       Impact factor: 2.493

2.  Cardiac troponin I for the diagnosis of acute myocardial infarction in the emergency department.

Authors:  M D'Costa; E Fleming; M C Patterson
Journal:  Am J Clin Pathol       Date:  1997-11       Impact factor: 2.493

3.  Elevated CK-MB with normal total creatine kinase in suspected myocardial infarction: associated clinical findings and early prognosis.

Authors:  R A Hong; J D Licht; J Y Wei; G V Heller; A S Blaustein; R C Pasternak
Journal:  Am Heart J       Date:  1986-06       Impact factor: 4.749

4.  Analytic and clinical evaluation of the Abbott AxSYM cardiac troponin I assay.

Authors:  K M ver Elst; J P Chapelle; P Boland; J S Demolder; F K Gorus
Journal:  Am J Clin Pathol       Date:  1999-12       Impact factor: 2.493

5.  Myocardial injury in critically ill patients.

Authors:  S R Beck
Journal:  JAMA       Date:  1995-12-06       Impact factor: 56.272

6.  Greater frequency of increased cardiac troponin T than increased cardiac troponin I in patients with chronic renal failure.

Authors:  D Li; I Jialal; J Keffer
Journal:  Clin Chem       Date:  1996-01       Impact factor: 8.327

7.  Serum concentrations of cardiac troponin I in sudden death: a pilot study.

Authors:  S J Cina; D J Li; D W Chan; J K Boitnott; R H Hruban; J E Smialek
Journal:  Am J Forensic Med Pathol       Date:  1998-12       Impact factor: 0.921

8.  Cardiac troponin I. A marker with high specificity for cardiac injury.

Authors:  J E Adams; G S Bodor; V G Dávila-Román; J A Delmez; F S Apple; J H Ladenson; A S Jaffe
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

9.  Myocardial injury in critically ill patients. A frequently unrecognized complication.

Authors:  T M Guest; A V Ramanathan; P G Tuteur; K B Schechtman; J H Ladenson; A S Jaffe
Journal:  JAMA       Date:  1995-06-28       Impact factor: 56.272

10.  Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue.

Authors:  G S Bodor; D Porterfield; E M Voss; S Smith; F S Apple
Journal:  Clin Chem       Date:  1995-12       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.